Transition period for TRIPS implementation for LDCs: Implications for local production of medicines in the East African community - Nirmalya Syam (South Centre, 2014)
Keywords: 300; TRIPS; Immaterialgüterrechte; Arzneimittel; Pharmaindustrie; Entwicklungsländer; Uganda; Tansania; Burundi